Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

11.30

-0.65 (-5.44%)

Sep 23, 2026, 10:11 AM EDT - Market open

Telix Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	890.79	803.79	516.55	332.98	108.81	5.52
Revenue Growth	10.82%	55.61%	55.13%	206.01%	1870.12%	37.33%
Gross Profit	423.71	381.85	319.49	203.28	64.52	3.67
Operating Income	55.26	19.29	55.88	34.98	-50.37	-59.08
Net Income	33.5	-7.13	33.69	4.21	-70.74	-58.54
Earnings Per Share	0.10	-0.02	0.10	0.01	-0.23	-0.21
EPS Growth	-	-	650.77%	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024
Manufacturing Solutions	277.07	245.11	1.82	0.28
Precision Medicine	704.73	621.93	508.51	329.21
Inter-Segment Elimination	-96.3	-72.51	-	-
Therapeutics	-	9.27	6.23	3.5
Total	890.79	803.79	516.55	332.98

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	251.91	141.87	440	84.3	79.07	16.02
Total Debt	579.86	467.11	360.16	12.26	7.1	1.85
Net Cash (Debt)	-327.95	-325.24	79.84	72.03	71.97	14.18
Net Cash Growth	-	-	10.84%	0.09%	407.61%	-75.74%
Net Cash Per Share	-0.94	-0.96	0.23	0.22	0.23	0.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-12.01	-17.29	27.49	14.27	-43.48	-43.14
Capital Expenditures	-33.48	-25.69	-9.12	-6.31	-4.78	-0.97
Free Cash Flow	-45.49	-42.99	18.37	7.97	-48.26	-44.11
Free Cash Flow Growth	-	-	130.64%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.57%	47.50%	61.85%	61.05%	59.29%	66.46%
Operating Margin	6.20%	2.40%	10.82%	10.51%	-46.29%	-1069.60%
Pretax Margin	3.24%	-0.66%	7.34%	0.78%	-61.60%	-1059.31%
Profit Margin	3.76%	-0.89%	6.52%	1.26%	-65.01%	-1059.90%
FCF Margin	-5.11%	-5.35%	3.56%	2.39%	-44.35%	-798.67%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	115.93	-	151.34	528.32	-	-
P/FCF Ratio	-	-	277.46	279.08	-	-
PS Ratio	4.36	3.15	9.87	6.68	14.37	290.85